Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > This $3 BioTech Stock could EXPLODE SOON!! Why?

<< Previous

Bullboard Posts

Next >>

Comment by GameChangerBeton Jun 11, 2021 12:27pm

136 Views

Post# 33372712

RE:RE:RE:RE:RE:RE:RE:This $3 BioTech Stock could EXPLODE SOON!! Why?

They haven't necessarily seen these videos, they've simply retained a 3rd party who's involved in these types of outreach programs. As a matter of fact what prompted me to conatact them was that I felt the video from a couple weeks ago was incredibly amateur in nature, both in terms of the content and the pitch. I flat out told them I would have been able to do a better job in articulating Antibe's mission and story.

I forwarded the video to them so they can clearly see what I was talking about and they did say that they hadn't seent the video.
Anyhow from what I gather they're just exploring different marketing options, but their focus as said by them, remains on institutions, primarily the US side which is where the major influx of money will come from once we're listed on that side.

MasterAlgae wrote:
Wow they do know about it, and they/we did pay for it....

MasterAlgae wrote: I agree with your points Mugs - Note: Antibe did not pay for this video, they may not even be aware of it. It says a third party paid for it. Not sure who that could be, if indeed it is true...

MrMugsy wrote:

Hey ... I'm not knocking the video ... it was fun for existing shareholders to watch and I appreciate it being posted because it's killing some time for us.

But ... that's not going to gain us any traction going forward - IMO. It carried pics and video clips that made 95% of the visual unrelated to ATE - just fluff that could have been added to almost any science discussion for a high school presentation. The biggest benefit was the excitement in his voice but in the end ... he was just repeating what he understood from reading the presentation.

It's great that others are doing this ... just not where the company really needs to focus.

Product development, drug advancement and negotiations will drive our value in the short to medium term - IMO. The two investors we should really focus on right now is the Institutional Investor and the drug partners. The retail investor will just follow along once that happens.

Cheers to the rest of 2021 to get things done !!!